Part One is why so many women and gender-diverse people carry a late ADHD or autism diagnosis, the "Masking Tax" that comes with decades of performing fine, and how eerily similar trauma symptoms can look to neurodivergence on paper — hypervigilance, scanning a room, the lot. Part Two picks up where that leaves a lot of us: reaching for medicinal cannabis to cope, often years before any diagnosis, and asking honestly whether the evidence backs that up or whether it's vibes wearing a lab coat. Australia's exploding millennial ADHD prescribing numbers, the newest CBD trial out of Deakin University, ABC News (2026, April). "Australian women have overtaken men in prescribing rates for ADHD medication," analysis of UNSW dispensing data, FY2017–FY2024. Aran, A., Harel, M., Cassuto, H., Polyansky, L., Schnapp, A., Wattad, N., et al. (2021). "Cannabinoid treatment for autism: A proof-of-concept randomized trial." Molecular Autism, 12(1), 6. "Autism, ADHD, and Complex PTSD — A Clinical Perspective on Overlap, Assessment, and Recovery." (2026). Brainz Magazine. Brabete, A.C., Greaves, L., Hemsing, N., & Stinson, J. (2020). "Sex- and Gender-Based Analysis in Cannabis Treatment Outcomes: A Systematic Review." International Journal of Environmental Research and Public Health, 17(3), 872. Cairns, E.A., Benson, M.J., Bedoya-Pérez, M.A., Macphail, S.L., Mohan, A., Cohen, R., Sachdev, P.S., & McGregor, I.S. (2023). "Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing." Frontiers in Pharmacology, 14, 1142680. Cooper, R.E., Williams, E., Seegobin, S., Tye, C., Kuntsi, J., & Asherson, P. (2017). "Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial." European Neuropsychopharmacology, 27(8), 795–808. Craddock, E. (2024). "Being a Woman Is 100% Significant to My Experiences of Attention Deficit Hyperactivity Disorder and Autism..." Qualitative Health Research, 34(14), 1442–1455. Deakin University (2026, March). "Cannabidiol (CBD) shows benefits for autistic children." Media release. Efron, D., Freeman, J.L., Cranswick, N., Payne, J.M., Mulraney, M., Prakash, C., Lee, K.J., Taylor, K., & Williams, K. (2021). "A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability." British Journal of Clinical Pharmacology, 87(2), 436–446. "Gender differences in autism prevalence: origins of bias and its current scientific relevance." (2026). Frontiers in Psychiatry. Karhson, D.S., LaFrance, E.M., & Cuttler, C. (2025). "Acute effects of cannabis on core and co-occurring features associated with autism spectrum disorder in adults." Scientific Reports, 15(1), 39849. Mitchell, J.T., Sweitzer, M.M., Tunno, A.M., Kollins, S.H., & McClernon, F.J. (2016). "'I Use Weed for My ADHD': A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD." PLOS ONE, 11(5), e0156614. Parrella, N.-F., Hill, A.T., Enticott, P.G., Botha, T., Catchlove, S., Downey, L., & Ford, T.C. (2026). "Effects of Cannabidiol on Social Relating, Anxiety, and Parental Stress in Autistic Children: A Randomized Controlled Crossover Trial." Autism Research, 19(2), e70159. Parrella, N.-F., quoted in PsyPost (2026, March). "New trial suggests CBD oil could lower anxiety in autistic children and reduce parenting stress."PTSD UK. "Can PTSD be mistaken for ADHD?"